Search results
Plus Therapeutics Inc (PSTV) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...
GuruFocus.com via Yahoo Finance· 5 hours agoThe company is still in the early stages of discussion with the FDA regarding the multi-dose expansion arm for their Phase 1 trial, indicating potential delays in trial progression ...
WHO clears Takeda's dengue vaccine
Reuters via AOL· 1 day agoThe approval, called a prequalification, comes amidst a surge in mosquito-borne viral infections across Asia, Africa, and the Americas, including new...
Lumos Pharma Inc (LUMO) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...
GuruFocus.com via Yahoo Finance· 5 hours agoResearch and development expenses increased by $2.9 million due to higher licensing and clinical trial expenses, adding financial pressure as the company progresses towards ...
7 of the best river cruises around the world for 2024
The Independent via Yahoo News· 14 minutes agoEmerald Cruises lets you see the best of the Danube with the addition of a hefty dose of traditional...
Earnings call: Biora Therapeutics reports progress on NaviCap and BioJet platforms By Investing.com
Investing.com· 13 hours agoBiora Therapeutics (NASDAQ:BIOR) has announced significant advancements in its NaviCap and BioJet...
Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...
GuruFocus.com via Yahoo Finance· 5 hours agoNet Loss (Q1 2024): $37.2 million, or $0.63 per share. Net Loss (Q4 2023): $9.1 million, or $0.15 per share. Cash and Investments (As of March 31, 2024) ...
Column: No Mow May should be 'No Spray May': Let's stop abusing Mother Earth
The Palm Beach Post via Yahoo News· 3 hours agoBut mowing isn’t the real issue; this month would be better called “No Spray May” as we need to stop...
How to Prepare for the Next Solar Storm
Time via AOL· 25 minutes agoThat was distilled down to a PDF procedure that sits on the desks of the Transpower operators. “They activated it this [past] weekend,” says Welling,...
BioAtla Inc (BCAB) (Q1 2024) Earnings Call Transcript Highlights: Strategic Adjustments and ...
GuruFocus.com via Yahoo Finance· 1 day agoExpected Operating Cash Burn: Approximately $20 million for Q2 2024, with a decrease anticipated in the second half of the year. Funding Operations: Current...and an 86% disease ...
Takeda’s dengue vaccine obtains WHO prequalification
Pharmaceutical Technology via Yahoo Finance· 4 hours agoIt is designed to be administered in a two-dose regimen with an interval of three months between doses. Sanofi Pasteur’s CYD-TDV dengue vaccine had...
